Genome-wide analysis of LPS-induced inflammatory response in the rat ventral hippocampus: Modulatory activity of the antidepressant agomelatine

Behavioral and neurochemical characterization of TrkB-dependent mechanisms of agomelatine in glucocorticoid receptor-impaired mice

(2016) F. Boulle et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Integrating neuroimmune systems in the neurobiology of depression

(2016) Eric S. Wohleb et al.   NATURE REVIEWS NEUROSCIENCE

Stress-induced anhedonia is associated with the activation of the inflammatory system in the rat brain: Restorative effect of pharmacological intervention

(2016) Andrea C. Rossetti et al.   PHARMACOLOGICAL RESEARCH

Inflammation and clinical response to treatment in depression: A meta-analysis

(2015) R. Strawbridge et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Erratum: Sex differences in glutamate receptor gene expression in major depression and suicide

(2015) A L Gray et al.   MOLECULAR PSYCHIATRY

Hippocampal neuroplasticity in major depressive disorder

(2015) N.V. Malykhin et al.   NEUROSCIENCE

The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders

(2015) G.Z. Réus et al.   NEUROSCIENCE

Effect of subchronic administration of agomelatine on brain energy metabolism and oxidative stress parameters in rats

(2015) Aline Haas de Mello et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Comorbidity between Type 2 Diabetes and Depression in the Adult Population: Directions of the Association and Its Possible Pathophysiological Mechanisms

(2015) Line Iden Berge et al.   International Journal of Endocrinology

CXC chemokine ligand 12 (CXCL12) and its receptor CXCR4

(2014) Takashi Nagasawa   JOURNAL OF MOLECULAR MEDICINE-JMM

Structural Changes in Hippocampal Subfields in Major Depressive Disorder: A High-Field Magnetic Resonance Imaging Study

(2013) Yushan Huang et al.   BIOLOGICAL PSYCHIATRY

Chemokines and the hippocampus: A new perspective on hippocampal plasticity and vulnerability

(2013) Lauren L. Williamson et al.   BRAIN BEHAVIOR AND IMMUNITY

Modulation of the inflammatory response in rats chronically treated with the antidepressant agomelatine

(2013) Raffaella Molteni et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Altered inflammatory responsiveness in serotonin transporter mutant rats

(2013) Flavia Macchi et al.   Journal of Neuroinflammation

Upregulation of mGlu2 Receptors via NF-κB p65 Acetylation Is Involved in the Proneurogenic and Antidepressant Effects of Acetyl-L-Carnitine

(2013) Bruna Cuccurazzu et al.   NEUROPSYCHOPHARMACOLOGY

L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors

(2013) C. Nasca et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Current status of chemokines in the adult CNS

(2013) Annabelle Réaux-Le Goazigo et al.   PROGRESS IN NEUROBIOLOGY

Lipopolysaccharide-induced anhedonia is abolished in male serotonin transporter knockout rats: An intracranial self-stimulation study

(2012) Floor van Heesch et al.   BRAIN BEHAVIOR AND IMMUNITY

Emerging drugs for major depressive disorder

(2012) Kevin Ryan Connolly et al.   EXPERT OPINION ON EMERGING DRUGS

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression

(2012) Charles L. Raison et al.   JAMA Psychiatry

Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes

(2012) S J Sukoff Rizzo et al.   Translational Psychiatry

Cross-national epidemiology of DSM-IV major depressive episode

(2011) Evelyn Bromet et al.   BMC Medicine

Towards a glutamate hypothesis of depression

(2011) Gerard Sanacora et al.   NEUROPHARMACOLOGY

Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior

(2011) Ebrahim Haroon et al.   NEUROPSYCHOPHARMACOLOGY

A psychoneuroimmunological review on cytokines involved in antidepressant treatment response

(2010) Debbie G. A. Janssen et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Agomelatine, the first melatonergic antidepressant: discovery, characterization and development

(2010) Christian de Bodinat et al.   NATURE REVIEWS DRUG DISCOVERY

Are the Dorsal and Ventral Hippocampus Functionally Distinct Structures?

(2010) Michael S. Fanselow et al.   NEURON

Interleukin-1 Receptor Activation by Systemic Lipopolysaccharide Induces Behavioral Despair Linked to MAPK Regulation of CNS Serotonin Transporters

(2010) Chong-Bin Zhu et al.   NEUROPSYCHOPHARMACOLOGY

Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine

(2010) Francesca Calabrese et al.   PSYCHOPHARMACOLOGY

A Meta-Analysis of Cytokines in Major Depression

(2009) Yekta Dowlati et al.   BIOLOGICAL PSYCHIATRY

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

(2009) Shahin Akhondzadeh et al.   DEPRESSION AND ANXIETY

SDF-1α/CXCL12 enhances GABA and glutamate synaptic activity at serotonin neurons in the rat dorsal raphe nucleus

(2009) Silke Heinisch et al.   NEUROPHARMACOLOGY

Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis

(2009) M Bryant Howren et al.   PSYCHOSOMATIC MEDICINE

IL-6 mediated alterations on immobile behavior of rats in the forced swim test via ERK1/2 activation in specific brain regions

(2008) Tung-Huan Wu et al.   BEHAVIOURAL BRAIN RESEARCH

Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders

(2008) H ANISMAN et al.   PROGRESS IN NEUROBIOLOGY

From inflammation to sickness and depression: when the immune system subjugates the brain

(2007) Robert Dantzer et al.   NATURE REVIEWS NEUROSCIENCE